UNC2025 hydrochloride |
| رقم الكتالوجGC37857 |
هيدروكلوريد UNC2025 هو أحد مثبطات Mer / Flt3 القوية ، والتنافسية ATP ، وفعالة للغاية عن طريق الفم مع قيم IC التي تبلغ 0.74 نانومتر و 0.8 نانومتر ، على التواليهيدروكلوريد UNC2025 هو> انتقائية 45 ضعفًا لـ MERTK بالنسبة إلى Axl (IC50 = 122 نانومتر ؛ Ki = 13.3 نانومتر)يُظهر هيدروكلوريد UNC2025 خصائص PK ممتازة ، ويمكن استخدامه للتحقيق في سرطان الدم الحاد
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2070015-17-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
UNC2025 hydrochloride is a potent and orally bioavailable Mer/Flt3 dual inhibitor with IC50 of 0.8/0.74 nM for Mer/Flt3.IC50 value: 0.8/0.74 nM (MER/FLT3)Target: Mer/Flt3 inhibitorUNC2025 was capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that 11 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined.
[1]. Zhang W, et al. UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor. J Med Chem. 2014 Aug 28;57(16):7031-41.
Average Rating: 5 (Based on Reviews and 1 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *